Daiwa Securities Group Inc. Neurocrine Biosciences Inc Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 11,798 shares of NBIX stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,798
Previous 8,801
34.05%
Holding current value
$1.41 Million
Previous $1.21 Million
12.21%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding NBIX
# of Institutions
623Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.19 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$613 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$307 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$222 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...